Literature DB >> 8040267

Interleukin-10 inhibits apoptotic cell death in infectious mononucleosis T cells.

K Taga1, J Chretien, B Cherney, L Diaz, M Brown, G Tosato.   

Abstract

T lymphocytes from patients with acute EBV-induced infectious mononucleosis rapidly die by apoptosis in vitro. Because human and viral IL-10 are likely to be induced during acute EBV infection and display a variety of functions on human T cells, we examined IL-10 effects on infectious mononucleosis T cell death. After 12 h of incubation in medium alone, only 35.6 (+/- 8.2%) of the originally seeded infectious mononucleosis T cells were viable. Addition of human IL-10 (100 U/ml) to T cell cultures significantly improved recovery of viable cells (71.3 +/- 6.2%, P = 0.0156). Viral IL-10 had comparable effects to human IL-10 in this system. Protection from death by human and viral IL-10 (100 U/ml) was dose dependent and continued over a 6-d culture period. The human IL-10 effect was neutralized by the anti-human IL-10 mAb 19F1. Morphology and analysis of DNA after separation on agarose gels showed that IL-10 inhibits loss of cell volume, chromatin condensation, and DNA fragmentation, characteristics of death by apoptosis. As assessed by [3H]thymidine incorporation, the T cells were not induced to proliferate by IL-10 above the level exhibited when first removed from blood. T cells protected from death by IL-10 proliferated to IL-2 and spontaneously killed sensitive targets as effectively as medium-precultured T cells. Thus, IL-10 promotes the survival of infectious mononucleosis T cells otherwise destined to die by apoptosis and may be critical for the establishment of immunologic memory after resolution of the illness.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8040267      PMCID: PMC296304          DOI: 10.1172/JCI117315

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  55 in total

1.  Emergence of suppressor cells of immunoglobulin synthesis during acute Epstein-Barr virus-induced infectious mononucleosis.

Authors:  B F Haynes; R T Schooley; C R Payling-Wright; J E Grouse; R Dolin; A S Fauci
Journal:  J Immunol       Date:  1979-11       Impact factor: 5.422

2.  Epstein-Barr virus recombinants with specifically mutated BCRF1 genes.

Authors:  S Swaminathan; R Hesselton; J Sullivan; E Kieff
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

3.  Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI.

Authors:  K W Moore; P Vieira; D F Fiorentino; M L Trounstine; T A Khan; T R Mosmann
Journal:  Science       Date:  1990-06-08       Impact factor: 47.728

4.  In vivo production of interleukin-10 by malignant cells in AIDS lymphomas.

Authors:  D Emilie; R Touitou; M Raphael; M Peuchmaur; O Devergnee; D Rea; J Coumbraras; M C Crevon; L Edelman; I Joab
Journal:  Eur J Immunol       Date:  1992-11       Impact factor: 5.532

5.  Interleukin-2 programs mouse alpha beta T lymphocytes for apoptosis.

Authors:  M J Lenardo
Journal:  Nature       Date:  1991-10-31       Impact factor: 49.962

Review 6.  NIH conference. Epstein-Barr virus infections: biology, pathogenesis, and management.

Authors:  S E Straus; J I Cohen; G Tosato; J Meier
Journal:  Ann Intern Med       Date:  1993-01-01       Impact factor: 25.391

7.  Analysis and discrimination of necrosis and apoptosis (programmed cell death) by multiparameter flow cytometry.

Authors:  C Dive; C D Gregory; D J Phipps; D L Evans; A E Milner; A H Wyllie
Journal:  Biochim Biophys Acta       Date:  1992-02-03

8.  Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes.

Authors:  M Kobayashi; L Fitz; M Ryan; R M Hewick; S C Clark; S Chan; R Loudon; F Sherman; B Perussia; G Trinchieri
Journal:  J Exp Med       Date:  1989-09-01       Impact factor: 14.307

9.  Interleukin 10: a novel stimulatory factor for mast cells and their progenitors.

Authors:  L Thompson-Snipes; V Dhar; M W Bond; T R Mosmann; K W Moore; D M Rennick
Journal:  J Exp Med       Date:  1991-02-01       Impact factor: 14.307

10.  The significance of low bcl-2 expression by CD45RO T cells in normal individuals and patients with acute viral infections. The role of apoptosis in T cell memory.

Authors:  A N Akbar; N Borthwick; M Salmon; W Gombert; M Bofill; N Shamsadeen; D Pilling; S Pett; J E Grundy; G Janossy
Journal:  J Exp Med       Date:  1993-08-01       Impact factor: 14.307

View more
  18 in total

1.  ICAM-1, soluble-CD23, and interleukin-10 concentrations in serum in renal-transplant recipients with Epstein-Barr virus reactivation.

Authors:  M W Hornef; G Bein; D Wilhelm; L Fricke; H Kirchner
Journal:  Clin Diagn Lab Immunol       Date:  1997-09

2.  Cytokine production in the immune response to murine gammaherpesvirus 68.

Authors:  S R Sarawar; R D Cardin; J W Brooks; M Mehrpooya; R A Tripp; P C Doherty
Journal:  J Virol       Date:  1996-05       Impact factor: 5.103

3.  Interleukin-10 rescues T cells from apoptotic cell death: association with an upregulation of Bcl-2.

Authors:  S B Cohen; J B Crawley; M C Kahan; M Feldmann; B M Foxwell
Journal:  Immunology       Date:  1997-09       Impact factor: 7.397

4.  Chemokine programming dendritic cell antigen response: part II - programming antigen presentation to T lymphocytes by partially maintaining immature dendritic cell phenotype.

Authors:  Jaehyung Park; James D Bryers
Journal:  Immunology       Date:  2013-05       Impact factor: 7.397

5.  The role of interleukin-10 in the inhibition of T-cell proliferation and apoptosis mediated by parainfluenza virus type 3.

Authors:  S Sieg; C King; Y Huang; D Kaplan
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

Review 6.  Challenges and future perspectives of T cell immunotherapy in cancer.

Authors:  Maria Teresa P de Aquino; Anshu Malhotra; Manoj K Mishra; Anil Shanker
Journal:  Immunol Lett       Date:  2015-06-19       Impact factor: 3.685

7.  Altered IL-10 levels in trauma patients' M phi and T lymphocytes.

Authors:  C L Miller-Graziano; A K De; K Kodys
Journal:  J Clin Immunol       Date:  1995-03       Impact factor: 8.317

Review 8.  Post-transplant lymphoproliferative disease (PTLD): lymphokine production and PTLD.

Authors:  G Tosato; J Teruya-Feldstein; J Setsuda; S E Pike; K D Jones; E S Jaffe
Journal:  Springer Semin Immunopathol       Date:  1998

9.  Expansion of a CD28-intermediate subset among CD8 T cells in patients with infectious mononucleosis.

Authors:  Hiroshi Uda; Toru Mima; Norihiko Yamaguchi; Yoshinori Katada; Masayuki Fukuda; Naohiko Fujii; Kojiro Nakamura; Osamu Saiki
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

10.  Nucleic acid sequence-based amplification, a new method for analysis of spliced and unspliced Epstein-Barr virus latent transcripts, and its comparison with reverse transcriptase PCR.

Authors:  A A Brink; M B Vervoort; J M Middeldorp; C J Meijer; A J van den Brule
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.